#VisualAbstract: Obeticholic acid for the treatment of non-alcoholic steatohepatitis
1. Obeticholic acid, a farnesoid X receptor agonist, prompts fibrosis improvement in patients with non-alcoholic steatohepatitis (NASH) Evidence Rating Level: 1 ...